sglt2 inhibitors vs glp 1 agonists Criteria for recommendation of or GLP-1 receptor SGLT-2 inhibitors and GLP-1 receptor

Conclusions The findings of this meta-analysis of seven RCTs (6609 participants) suggest a dose-dependent superiority of all three tirzepatide maintenance doses on glycaemic control, not only vs placebo but also vs long-acting GLP-1 RAs and basal insulin regimens

doi: 10.1056/NEJMoa1901118 [DOI] [PubMed] [Google Scholar] 83

Health , vol

PMID: 34385227

Studies with a Comparison Group and GLP1-RAs and SGLT2is Used Simultaneously Table 2 presents the studies that examined the simultaneous use of combined therapy

The newly discovered conjunctive use of GLP-1RA can improve clinical outcomes in patients with multiple chronic illnesses that have overlapping pathophysiology and help improve quality of life with early introduction